Fig. 5: Nomogram to predict the risk of recurrence in stage II/III CRC patients. | npj Precision Oncology

Fig. 5: Nomogram to predict the risk of recurrence in stage II/III CRC patients.

From: High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer

Fig. 5

a Nomogram to predict DFS. Calibration curves to predict 8-year disease-free survival in (b) the training cohort, (c) the internal validation cohort, and (d) the external validation cohort; The nomogram-predicted probability is plotted on the x-axis and the actual survival is plotted on the y-axis. PS Proteomic signature, CRC Colorectal cancer, ROC Receiver operator characteristic, DFS Disease-free survival.

Back to article page